CARLY JONES: Open Payments
NPI 1205557683 · BLACKLICK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 19 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $515 · 2025 $559
Food & beverage: $364Education: $195
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $195 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| GENZYME CORPORATION | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Optinose US, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
Products named: DUPIXENT, Xhance, NUCALA, Rhapsido, FASENRA, NEFFY.
Industry payments across OH — which companies pay providers there.
